Search

everythinglearnresearchcommunity

for

Search:↓

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

17b-Estradiol in skin affects hair growth and tumor promotion.

CYP11A1 is crucial for skin health and disease by producing important steroids.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Potential new drugs for treating PCOS were identified.

The compound was successfully made and shows potential for treating prostate cancer.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Estrogen affects how vitamin A is processed in mouse skin, which may impact acne treatment, hair growth, and skin defense.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

A woman with a specific mutation causing adrenal gland issues faced fertility problems, but careful hormone therapy helped her manage it successfully.